Table of Contents

company-logo

Coherus BioSciences, Inc., a biopharmaceutical company, focuses on the biosimilar and immuno-oncology market primarily in the United States. The company markets UDENYCA, a biosimilar to Neulasta, a long-acting granulocyte stimulating colony factor in the United States. Its pipeline products include biosimilars of Humira, Avastin, and Lucentis. The company also develops Toripalimab, a novel anti-PD-1 antibody for second-line treatment of melanoma in China; Bevacizumab biosimilar; and CHS-1420, an anti-TNF product candidate, as an adalimumab biosimilar; Ranibizumab biosimilar. Coherus BioSciences, Inc. has license agreements with Selexis SA; AbbVie, Inc.; Pfizer, Inc.; Bioeq AG; Innovent Biologics (Suzhou) Co., Ltd.; and Junshi Biosciences. The company was formerly known as BioGenerics, Inc. and changed its name to Coherus BioSciences, Inc. in April 2012. Coherus BioSciences, Inc. was incorporated in 2010 and is headquartered in Redwood City, California.

Coherus BioSciences Dividend Announcement

• Coherus BioSciences does not currently offer dividends, we're keeping a close eye on its growth potential and financial developments.
• Stay tuned for updates on Coherus BioSciences dividend policy and future announcements. In the meantime, explore other dividend-yielding opportunities on our website.

Coherus BioSciences Dividend History

Coherus BioSciences Dividend Yield

Coherus BioSciences current trailing twelve-month (TTM) dividend yield is -%. Interested in purchasing Coherus BioSciences stock? Use our calculator to estimate your expected dividend yield:

Coherus BioSciences Financial Ratios

P/E ratio-309.79
PEG ratio27.27
P/B ratio-1.58
ROE0.40%
Payout ratio0.00%
Current ratio1.25
Quick ratio1.09
Cash Ratio0.33

Coherus BioSciences Dividend FAQ

Does Coherus BioSciences stock pay dividends?
Coherus BioSciences does not currently pay dividends to its shareholders.
Has Coherus BioSciences ever paid a dividend?
No, Coherus BioSciences has no a history of paying dividends to its shareholders. Coherus BioSciences is not known for its dividend payments.
Why doesn't Coherus BioSciences pay dividends?
There are several potential reasons why Coherus BioSciences would choose not to pay dividends to their shareholders:

1. Growth opportunities: Companies, especially in fast-growing industries like technology, reinvest earnings into expansion, R&D, or acquisitions to fuel future growth and increase company value.

2. Tax implications: Not paying dividends can reduce the tax burden on shareholders, who may prefer to defer taxes until selling shares and realizing capital gains.

3. Investor preferences: Some investors prefer companies to reinvest profits for higher long-term returns, particularly those seeking capital appreciation over income.

4. Capital allocation priorities: Companies may allocate cash to pay down debt, fund share buybacks, or invest in projects with higher returns than dividends.

5. Market expectations: In certain sectors, like technology, reinvesting profits for growth and innovation is often prioritized over distributing dividends to shareholders.
Will Coherus BioSciences ever pay a dividend?
The decision for a company to pay dividends depends on various factors including its financial performance, growth prospects, capital allocation priorities, and shareholder preferences. While Coherus BioSciences has not paid dividends historically and has instead focused on reinvesting its earnings for growth, it's ultimately up to the company's management and board of directors to decide whether to initiate a dividend policy in the future.
Is Coherus BioSciences a dividend aristocrat?
Coherus BioSciences is not considered a Dividend Aristocrat. The term "Dividend Aristocrat" is typically used to describe a company in the S&P 500 index that has increased its dividend payouts for at least 25 consecutive years.
Is Coherus BioSciences a dividend king?
Coherus BioSciences is not classified as a "Dividend King". A Dividend King is a company that has managed to increase its dividend payouts for 50 consecutive years or more, which is an even more selective group than the Dividend Aristocrats.
Is Coherus BioSciences a dividend stock?
No, Coherus BioSciences is not considered a dividend stock. A dividend stock is a stock of a company that regularly pays out dividends to its shareholders.
How to buy Coherus BioSciences stocks?
To buy Coherus BioSciences you need a brokerage account. Open an account with a reputable brokerage firm that offers access to the stock market. Consider factors such as fees and account minimums.

Place an order: Use the brokerage's trading platform to place an order to buy Coherus BioSciences stock.

Remember that buying stocks involves risk, and it's important to carefully consider your investment goals, risk tolerance, and conduct thorough research before making any investment decisions.